FDA Drug recall D-0862-2017
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest…
- FDA Drug
- Class I
- ongoing
- Published 2017-05-31
On 2017-05-31 the FDA classified a Class I recall of Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest… by Hospira, citing presence of Particulate Matter: human hair found within an internal sample syringe.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0862-2017 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2017-04-21 |
| Published | 2017-05-31 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10
Reason
Presence of Particulate Matter: human hair found within an internal sample syringe.
Identifiers
| ndc | 0409-1775-40 |
|---|---|
| ndc | 0409-1775-10 |
| code_info | Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0862-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.